Immature Platelet Fraction as a Surrogate Marker of Thrombo-Inflammation in Hospitalized COVID-19 Patients
Open Access
Abstract
Although COVID-19 is associated with significant thrombo-inflammatory complications, reliable biomarkers to guide antithrombotic therapy remain limited. Immature platelet fraction (IPF) reflects platelet turnover and may indicate heightened thrombotic risk. We retrospectively analyzed 133 hospitalized COVID-19 patients (median age 68 years) at a single center. IPF and inflammatory markers (WBC, ANC, D-dimer, LDH, CRP) were measured on admission. Correlations between IPF and these biomarkers were assessed overall and in clinical subgroups (age, sex, disease severity, comorbidities, and treatment). We found that IPF was positively correlated with WBC and ANC in patients less than 70 years old (r = 0.36 and 0.33, respectively; p < 0.05), males, and those with moderate-to-severe disease. Among patients with congestive heart failure, IPF correlated strongly with D-dimer (r = 0.78, p = 0.013). Similar associations were observed in patients requiring enoxaparin or antiplatelet therapy. No significant correlations were found in patients age 70 or older. Based on these findings, we conclude that elevated IPF is associated with increased inflammatory and thrombotic activity in hospitalized COVID-19 patients, especially in younger, male, and more severe cases. These findings suggest IPF may serve as a dynamic marker for thrombo-inflammation and help identify patients who might benefit from more intensive antithrombotic therapy. Larger studies are warranted to validate IPF as a biomarker for personalized management of COVID-19.Keywords
This publication has 29 references indexed in Scilit:
- Immature platelets in patients with Covid-19: association with disease severityJournal of Thrombosis and Thrombolysis, 2021
- Immature platelets: a review of the available evidenceThrombosis Research, 2020
- Immature platelets in patients hospitalized with Covid-19Journal of Thrombosis and Thrombolysis, 2020
- Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentCell, 2020
- COVID-19 cytokine storm: the interplay between inflammation and coagulationThe Lancet Respiratory Medicine, 2020
- Inflammation, metaflammation and immunometabolic disordersNature, 2017
- Immature platelet fraction predicts coagulopathy-related platelet consumption and mortality in patients with sepsisThrombosis Research, 2016
- Heart failure and risk of venous thromboembolism: a systematic review and meta-analysisThe Lancet Haematology, 2016
- Association of Immature Platelets With Adverse Cardiovascular OutcomesJACC, 2014
- Immature platelet fraction in predicting sepsis in critically ill patientsIntensive Care Medicine, 2012